‌$Meta Materials Inc. Class A Preferred Stock(MMTLP)$  ‌each holder of Series A Preferred Stock as of 4 p.m. ET on December 12, 2022, (the record date for the distribution), will be entitled to receive one share of Next Bridge common stock for every one share of Series A Preferred Stock held as of the record date. The shares of Next Bridge common stock will be distributed on December 14, 2022 after the close of the trading markets, at which time (i) all of the shares of Series A Preferred Stock will be automatically cancelled, (ii) the holders of such Series A Preferred Stock will cease to have any rights with respect to such shares and (iii) the shares of Series A Preferred Stock, MMTLP, will no longer be tradable on the OTC market.

Thanks BC for fubo!!

$fuboTV Inc.(FUBO)$ thanks @BC

‌$AMD(AMD)$‌AMD (NASDAQ:AMD) today announced revenue for the first quarter of 2022 of $5.9 billion, gross margin of 48%, operating income of $951 million, operating margin of 16%, net income of $786 million and diluted earnings per share of $0.56. On a non-GAAP(*) basis, gross margin was 53%, operating income was $1.8 billion, net income was $1.6 billion and diluted earnings per share was $1.13.

‌$Genetic(GENE)$  ‌ ASX:GTG https://genetype.com/investor-centre/ Friday 28 November 2014 14-320MR Former Genetic Technologies CEO jailed for market manipulation Former Genetic Technologies Ltd chief executive Dr Mervyn Jacobson was today sentenced to a total term of two years and eight months imprisonment after being convicted of manipulating the share price of GTG on the Australia Securities Exchange (ASX:GTG). https://asic.gov.au/about-asic/news-centre/find-a-media-release/2014-releases/14-320mr-former-genetic-technologies-ceo-jailed-for-market-manipulation/ https://genetype.com/investor-centre/

‌$Tesla Motors(TSLA)$  ‌next stop 370!!

‌$Exela Technologies, Inc.(XELA)$  ‌Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The Company intends to timely request the hearing before the Panel which will stay the delisting of the Company’s securities pending the issuance of a decision by the Panel and the expiration of any extension the Panel may grant to the Company following the hearing. The Company has been informed that hearings are typically scheduled to occur approximately 30-45 days after the date of the hearing request. The request for a hearing must be received by the Nasdaq Hearings Department no later than 4:00 p.m. Eastern Time on January 12, 2023. There are no assurances however, that an extension